Long-term use of dopamine agonists in Parkinson's disease.
D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003342:Corpus Striatum / Q000032:analysis; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide; D011954:Receptors, Dopamine / Q000032:analysis; D013997:Time Factors
D004873:Ergolines; D011954:Receptors, Dopamine; D010479:Pergolide; D001971:Bromocriptine; D007980:Levodopa